SCHEMBL4207478

SCHEMBL4207478

COc1ccc(NS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c2c1C[C@@H](N(C)C)CC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.55
QRFPR Q96P65 1/20 0.55
ALDH1A1 P00352 3/20 0.49
POLB P06746 2/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CHRM2 P08172 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
DRD2 P14416 2/20 0.42
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
HSD11B1 P28845 1/20 0.40
HSD17B2 P37059 1/20 0.40
CYP19A1 P11511 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4205263 0.90 HTR6 (0.53) HTR6QRFPRALDH1A1POLBLMNA
SCHEMBL4205977 0.88 HTR6 (0.58) HTR6QRFPRALDH1A1LMNACHRM2
SCHEMBL4205721 0.88 HTR6 (0.58) HTR6QRFPRALDH1A1POLBLMNA
SCHEMBL4201649 0.88 HTR6 (0.58) HTR6QRFPRALDH1A1LMNACHRM2
SCHEMBL4199217 0.87 HTR6 (0.57) HTR6QRFPRALDH1A1POLBLMNA
SCHEMBL4216893 0.87 HTR6 (0.59) HTR6QRFPRALDH1A1POLBLMNA
SCHEMBL4204559 0.87 HTR6 (0.68) HTR6QRFPRALDH1A1POLBLMNA
SCHEMBL4202828 0.87 HTR6 (0.57) HTR6QRFPRALDH1A1LMNACHRM2
SCHEMBL4207489 0.87 HTR6 (0.57) HTR6QRFPRALDH1A1LMNACHRM2
SCHEMBL4207178 0.86 HTR6 (0.65) HTR6QRFPRHPGDL3MBTL1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090030038-A1 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor ASTRAZENECA AB (SE) 2009-01-29 US claimed
EP-1888517-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR AstraZeneca AB (SE) 2008-02-20 EP claimed
WO-2006126939-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR ASTRAZENECA AB (SE) 2006-11-30 WO claimed
US-20090030038-A1 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor ASTRAZENECA AB (SE) 2009-01-29 US disclosed
EP-1888517-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR AstraZeneca AB (SE) 2008-02-20 EP disclosed
WO-2006126939-A1 NOVEL 8-SULFONYLAMINO-3 AMINOSUBSTITUTED CHROMAN OR TETRAHYDRONAPHTALENE DERIVATIVES MODULATING THE 5HT6 RECEPTOR ASTRAZENECA AB (SE) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030038-A1 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor HTR6, HTR1A, HTR1D HTR6 1/4885QRFPR 81/4885ALDH1A1 2701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.